Preparing a Veterinary Practice for Sale: The 2026 Value-Building Roadmap

Key takeaways

• The work that moves your sale price happens 12 to 24 months before you go to market, not in the deal itself — the levers buyers pay for need a track record before they’ll underwrite them.
• Owner clinical dependence is the first thing a buyer checks — if you produce most of the practice’s revenue personally, you’re selling a job that leaves when you do, and buyers discount it roughly 1 to 2 additional multiples of EBITDA.
• A real practice manager and documented systems turn a practice that needs you into a practice a buyer can step into, and the management layer usually pays for itself many times over inside the prep window.
• A defensible normalized EBITDA (your operating profit after stripping out personal and one-time expenses) is what buyers actually multiply, and properly documented it typically runs 15 to 30 percent above the raw P&L number.
• The pre-sale financial review is a TE service on your side of the table, not an owner DIY project — it mirrors the buyer’s audit and fixes the price-cutting findings before any buyer ever sees your numbers.

A vet I’d worked alongside for years called me on a Sunday evening, which is when the real questions tend to come. He’d decided he wanted to retire in about 18 months.

His plan, as he described it, was to keep doing exactly what he’d done for 28 years, then call me the week he was ready and let me sell the practice.

I told him the plan was fine except for the timing of the call. The week he was ready to retire was the worst possible week to start.

The best possible week was that Sunday, a year and a half early, because almost everything that would determine his final number was work we could only do before a buyer ever entered the conversation.

That’s the subject of this article. Not how a sale works once it starts, and not what practices are worth in 2026.

This is the roadmap for the 12 to 24 months before you go to market, when the moves you make quietly decide whether you clear a 7 or an 11 on the same building.

Why preparation, not the deal, decides your number

Most owners think the sale price gets set during the sale. It doesn’t.

By the time buyers are looking at your practice, the inputs that drive their offer are already fixed, and you’re mostly negotiating around a number your own track record has already written.

The practice you bring to market is the practice buyers underwrite. They don’t pay for the practice you could build.

They pay for the trailing financials, the production profile, and the management depth that exist on the day they look.

That’s why the year or two before a sale is the highest-leverage window an owner ever gets. A point or two of multiple is not a rounding error.

On a practice producing $1 million in normalized EBITDA — your operating profit after stripping out the personal and one-time expenses the next owner won’t inherit — every additional multiplier point is another $1 million of headline value.

I’ve watched this play out enough times that I stop calling it a pattern and start calling it a rule. The owners who clear the top of their range almost always did the unglamorous preparation work first.

The market you’re preparing for in 2026

Before the roadmap, the lay of the land. The veterinary M&A market in 2026 rewards prepared practices more than it has in a few years, mostly because there are fewer practices on offer.

Capstone Partners‘ April 2026 Pet Sector M&A Update tracked 18 pet sector deals in the first months of 2026, more than double the 8 deals in the same window of 2025. Vet and Health accounted for half of those deals.

Annual transaction volume has settled near 350 practices a year, well off the more than 1,000 that changed hands at the 2021 peak. Demand from buyers stayed steady while supply contracted, and a tight supply puts a floor under valuations.

What that means for you as a seller is simple. In a thinner field of available practices, a well-prepared one stands out, and standing out is what produces competitive bidding.

The preparation work in this article is what separates your practice from the others a buyer is looking at the same quarter.

The underlying demand is real. AVMA’s 2025 Report on the Economic State of the Veterinary Profession found pet owners spending around $1,700 a year on their animals, roughly $200 more than the prior two years, with veterinary care accounting for 32.4 percent of total pet spending.

Buyers are acquiring into a sector with durable consumer demand.

The six levers that move your multiple

When I walk a vet through preparation over dinner, I draw the same short list every time. There are six levers that move the number, and the first five are entirely within your control in the 12 to 24 months before sale.

The sixth happens at the sale itself.

Here’s the roadmap in one view, ranked by how much each lever moves the multiple and how long it takes to pay off.

Value lever	What it does to the multiple	Lead time to credit
Reduce owner clinical dependence below 50%	Removes the largest single discount buyers apply; roughly 1-2 additional multiples of EBITDA	18-24 months (2-3 quarters of seasoned associate production)
Build a practice manager + documented systems	Turns a job into an asset a buyer can integrate; roughly 1-2 additional multiples of EBITDA	12-18 months
Three years of clean revenue growth	Buyers underwrite forward; growth earns a positive adjustment, flat or declining subtracts	24-36 months to show 3 full years
Protect and improve EBITDA margin	Sub-par margin signals inefficiency and pulls the multiple down; healthy margin earns the upper end of the range	12-18 months
Document a defensible normalized EBITDA	Lifts the number buyers actually multiply, typically 15-30% above raw P&L	3-6 months (with advisor)
Run a competitive process at sale	The single largest variable; consistently produces multiple additional turns of EBITDA	Happens at sale, not in prep

The five preparation levers compound. A practice that does three of them well doesn’t just stack three separate adjustments.

It presents as a fundamentally lower-risk acquisition, and lower risk is what pulls the whole offer up.

The sections that follow walk through each lever in the order buyers actually weight them, which is not always the order owners expect.

Lever 1: Get yourself out of the production seat

When sophisticated buyers run the numbers on a practice, the first thing they look at isn’t revenue or margin. It’s how much of the clinical work runs through the owner personally.

This is owner clinical dependence, and it’s the lever that moves the multiple most for the typical owner-operator. If you’re producing 70 percent or more of the practice’s revenue as a working vet, you’re not selling a practice the next owner can step into.

You’re selling a job, and the job walks out the door the day you do.

Buyers price that risk in directly. The penalty on an owner-heavy practice runs roughly 1 to 2 additional multiples of EBITDA, meaning a practice with diversified doctor production that would clear at 9 times earnings clears at 7 or 8 with concentrated production.

On a $1 million EBITDA practice, that gap is $1 million to $2 million of headline value.

The fix is the slowest of all the levers, which is exactly why it has to start first. Hiring an associate doesn’t credit your multiple the day they start.

Buyers want to see at least two and ideally three quarters of sustained associate production before they’ll factor it into the underwriting.

Here’s a pattern I see constantly. A solo owner comes to me running a beautiful practice, strong revenue, healthy margins, modern facility, and the only real problem is that he personally produces roughly four-fifths of the clinical work.

The first direct offer he’d received was fine but unremarkable.

We spend the better part of a year bringing in associates and systematically shifting his production share down. When the practice goes to market through a competitive process, it clears a much better number, the kind that changes retirement plans.

Same building, same financials underneath, different production profile and a different pool of buyers willing to compete for it.

The arithmetic on timing is unforgiving. If you’re 24 months from selling, an associate hire today is meaningful by the time you go to market.

If you’re 12 months out, the window to season the production is tight, and you may want to lean harder on the other levers while you do what you can on this one.

There’s a second benefit owners underrate. A practice that depends on retained associates is one buyers will pay to protect.

Per AAHA’s reporting on exit and entry strategies, some buyers tie part of the payout to the seller’s ability to keep key veterinarians on board for 12 to 24 months after closing, so the associate bench you build before sale also strengthens your hand inside the deal.

Lever 2: Build a practice that runs without you

This is the lever owners most often underweight, and it’s the one that most cleanly separates a practice from a job in a buyer’s eyes.

A practice that depends on the owner’s daily attention to run isn’t something a PE-backed group can plug into their portfolio. They want a practice they can integrate without rebuilding the operating layer underneath it.

The discount applied to a practice that runs through the owner’s calendar, versus one with a real practice manager, defined roles, and documented systems, is roughly 1 to 2 additional multiples of EBITDA. The signal a buyer is reading is continuity.

Will this practice still function the same way 6 months after the owner stops showing up every day?

The test is concrete. Who makes the call when you’re not there?

Does your practice manager have actual authority, or do decisions wait for you? Are your associates confident and productive on their own, or does everything route back through you?

Building that depth costs about 1 to 3 percent of revenue annually. On a $4 million revenue practice that’s roughly $40,000 to $120,000 a year for a stronger manager, defined leadership roles, and the time to document how the practice runs.

The math usually pays back many times over. The multiple uplift on a healthy mid-sized practice can run into six figures per point, against an annual investment that’s a fraction of that, and the payback lands well inside the typical 18 to 24 month prep window.

The documentation itself matters more than owners think. Write down how you handle client communication, appointment flow, inventory, hiring, and the financial close.

A practice with its systems on paper reads to a buyer as a practice that survives the transition, and that perception is worth real money at the table.

Lever 3: Show three years of clean, growing financials

PE-backed buyers underwrite forward. They’re not paying for the revenue you produced last year.

They’re paying for the EBITDA they’ll inherit and grow over the years until their own exit, and the best predictor they have is your recent trend.

A multi-year track record of revenue growth earns a positive multiple adjustment. Flat revenue subtracts at least a point.

Declining revenue is brutal, and sophisticated buyers will find a reason not to bid at all if they can.

The logic isn’t mysterious. When a financial buyer pays a healthy multiple today, they need the number to make sense after their integration costs and the multiple they’ll exit at several years out.

Growth supplies that math, and stagnation forces them to manufacture it themselves, which is harder and riskier than buying it already in motion.

Three years is the window buyers want to see, which is the other reason preparation can’t start the month you decide to sell. You can’t retroactively produce a clean three-year trend.

The growth doesn’t have to be dramatic. Steady single-digit annual revenue growth, driven by client retention, reactivating lapsed patients, tighter treatment-plan conversations, and disciplined pricing, reads far better than a single lumpy year.

The AVMA’s 2025 data shows the average practice’s active client count has been drifting down by roughly 95 clients a year since 2019, so a practice that’s holding or growing its client base is visibly bucking the trend, and buyers notice.

Just as important: keep the financials clean while you grow. Accurate profit and loss statements, payroll summaries, and production reports by doctor, reconciled and consistent across all three years, are the raw material everything else in preparation is built on.

Lever 4: Protect the margin buyers are scrutinizing

A practice running at a thin EBITDA margin signals operational inefficiency to buyers, and they pull the multiple down to compensate. The working norm for healthy companion-animal general practices runs in the high teens to low twenties as a percentage of revenue, and practices that sustain the upper end earn the upper end of their size tier’s multiple.

Margin is the lever with the shortest path to visible improvement, because it’s about operating discipline rather than a multi-year track record. The mechanics are unglamorous and they compound: cleaner inventory management, tighter technician utilization, better pricing discipline on services, and trimming wasted continuing-education and vendor spend.

iVET360, the operations-analytics firm focused on companion-animal practices, framed this concretely in one published analysis, noting that a single year of operational restructuring lifted one practice’s estimated worth by roughly $1.65 million, almost entirely through margin expansion. None of the moves behind that were dramatic.

They were operating habits, applied consistently.

There’s a benchmark worth knowing here. AVMA’s 2025 report puts average revenue at about $554,982 per veterinarian and $444,668 per exam room.

If your practice is well below those productivity marks, there’s margin to recover before sale, and recovering it shows up directly in the number a buyer multiplies.

A word of caution. Don’t cut your way to a margin that can’t survive the transition.

Slashing staff or deferring real maintenance to flatter a single year’s EBITDA is exactly the kind of thing a buyer’s review uncovers, and it costs more credibility than it gains in multiple. The goal is durable margin, not a cosmetic one.

Lever 5: Document a normalized EBITDA that survives scrutiny

The number on your P&L is not the number a buyer will pay against. The number that matters is normalized EBITDA, your earnings after stripping out the personal, one-time, and owner-specific expenses the next owner won’t inherit.

Buyers price your practice against the normalized number, and they will not normalize it for you. Their economic incentive runs the opposite direction, so the work of building a defensible normalized EBITDA falls to your side of the table, and it’s where first-time sellers most often leave money behind.

An add-back is an expense added back to reported profit because it’s personal to you or non-recurring. Here are the categories that tend to survive a buyer’s review, roughly in order of how much they move the number.

Owner compensation above market rate is usually the largest. If you pay yourself $400,000 and the going rate for a hired medical director with your responsibilities is $200,000, the $200,000 difference is an add-back, and on a multi-doctor practice that single item can move EBITDA $100,000 to $250,000.

Family members on payroll above market pay: the add-back is the portion of a spouse’s, child’s, or parent’s compensation that exceeds what an unrelated employee would earn in the same role. Documentation of their actual duties matters, because this is one buyers dig into.

Personal vehicle and travel run through the practice, plus owner personal insurance at premium levels, plus one-time legal and professional fees that don’t recur, plus continuing education above industry norms (the benchmark is roughly 1 to 1.5 percent of revenue). Each comes out cleanly only if it’s truly personal or non-recurring and the documentation supports it.

Properly documented normalization typically raises the EBITDA figure 15 to 30 percent above the raw P&L number. On a practice showing $620,000 of reported EBITDA, a defensible normalized figure might land near $810,000, and at a 10x multiple that’s roughly $1.9 million of additional sale price riding on getting the number right.

The discipline cuts both ways. Aggressive add-backs that get rejected don’t just cost you that one item.

They damage the credibility of the entire normalization, which a buyer then discounts more broadly. The goal is a number that’s both maximized and defensible, and those two things are in tension without experienced help.

Lever 6 happens at sale: run a competitive process

The five levers above are preparation. The sixth, and the largest of them all, happens at the sale itself, and it’s worth naming here because everything you build in preparation exists to make this final lever pay off.

Buyers offer their lowest defensible number when they don’t know who else is bidding. A direct conversation with one private equity buyer runs on the quiet assumption that you’ll likely accept some version of the opening range.

A competitive process flips that dynamic, because now every buyer knows they’re bidding against unknown alternatives, and their internal underwriting shifts upward.

This is what we built the Elite Selling System to do. We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group.

Per Octus’s 2025 sector research, multiples for typical private veterinary practices were lingering in the mid- to high single digits through early last year in single-bidder contexts. Those numbers describe what a financial buyer offers when nobody else is in the room, not what a well-prepared practice clears when several qualified buyers compete for it.

The connection back to preparation is the whole point. A competitive process produces its biggest results on a practice that’s genuinely ready, because a prepared practice gives every bidder fewer reasons to discount and more reasons to stretch.

The work in levers 1 through 5 is what turns competitive interest into a competitive price.

The pre-sale financial review: your side of the table

There’s one piece of preparation that owners regularly get wrong by trying to do it themselves, so it deserves its own section.

Before closing, the buyer’s accountants run a Quality of Earnings audit, the deep financial review that tests whether your EBITDA and add-backs hold up. They scrutinize your add-backs, revenue recognition, inventory valuation, and doctor productivity, and their findings commonly adjust the final purchase price several percentage points in either direction.

The mistake is thinking the right response is for the owner to commission their own version of that audit before going to market. That’s not how it works.

When we prepare a practice for sale, part of the work is a thorough pre-sale financial review on our side of the table, built around exactly the kind of scrutiny the buyers’ accountants will run, but done before any of those buyers see your numbers. That gives us months to clean up anything that wouldn’t survive a deep audit.

Questionable add-backs get tightened or removed. Revenue-recognition issues, services billed but not collected, deferred income, get reconciled.

Inventory valuation, especially in mixed-animal practices, gets corrected. Doctor productivity tracking that doesn’t quite tie to documented schedules gets fixed.

By the time the buyer’s accountants do their own review, the findings that would have been used to walk your price down have already been addressed. That work is part of how we prepare practices, and across the deals we’ve closed over the past four-plus years it’s almost always responsible for at least a multiplier point of additional sale value that would otherwise have leaked out in diligence.

A realistic timeline for the 12 to 24 months ahead

If you’re inside the 2-year window, here’s roughly how the work sequences.

Start the slow levers first. Associate hiring and case-shifting, plus building management depth, both need the most calendar time, so they go at the front.

The financial trend you want buyers to see is also accumulating in the background, which is why the earlier you start, the more of it you have to show.

In the middle of the window, the operating levers take hold. Margin discipline tightens, the practice manager grows into real authority, your production share is visibly declining, and the systems documentation gets written down rather than living in your head.

In the final stretch before market, the financial work comes forward. The normalized EBITDA gets documented, the add-back schedule gets built and supported, and the pre-sale financial review surfaces and fixes anything a buyer’s accountants would have caught.

The further ahead you start, the more of these run in parallel rather than in a rush. Per Today’s Veterinary Business and AAHA commentary on succession, owners who begin late find their options narrow, because the best outcomes, whether an associate buy-in or a competitive sale, are built over years, not weeks.

What to do next

Most of what I’ve laid out here is the conversation I’d want to have with a vet a year or two before they sell, ideally over dinner, with enough runway left to actually use it.

The single most valuable thing you can do early is get an honest read on where your practice stands today and which levers will move your number most. For one owner that’s the production seat.

For another it’s management depth or a margin that’s quietly eroded. The mix is different for every practice, and knowing yours is what turns a vague intention to sell into a plan that actually lifts the price.

If you’re inside that window, that’s exactly what we built our work to find out, before you’ve committed to anything and while there’s still time to move the number.

Get a Free Practice Value Estimate →

We pull your numbers ourselves, build the normalized EBITDA properly, run the pre-sale financial review that surfaces and fixes anything a buyer’s accountants would catch, identify the right group of buyers for your specific profile and geography, and send you back a defensible value range with the math behind it and a clear view of which preparation levers would move it most. The estimate is free and there’s no obligation to engage further.

The Transitions Elite engagement model is success-based. No upfront fees, no retainer.

We only get paid when a deal closes, and only out of the value our process delivers above what you would have realized on your own.

Further reading

These are the related TE resources I’d point any vet considering a sale toward. Each goes deep on one dimension of the decision, so this roadmap can stay focused on preparation.

• Veterinary practice EBITDA multiples in 2026 — what practices actually sell for by size and profile, and the math behind the multiple.
• Should I sell my veterinary practice? — the owner’s decision guide on whether, when, and to whom to sell.
• How to sell a veterinary practice — the step-by-step sale process from advisor engagement to closing.
• How to value a veterinary practice — the valuation methods and what drives the number.
• Our practice sale results — outcomes across the practices we’ve represented.
• About Transitions Elite — the team, the methodology, and the firm’s track record.

Frequently asked questions

How long does it take to prepare a veterinary practice for sale in 2026?

Plan on 12 to 24 months for the levers that actually move the multiple. The operational changes buyers pay for, such as reducing owner clinical production below half of the practice’s total and building real management depth, need several quarters of track record before a buyer will underwrite them.

Cleaning up financials and documenting normalized EBITDA can move faster, but the value-building work that lifts the multiple a point or two takes a year or more. Owners who start the year before they want to sell consistently clear higher than owners who go to market the month they decide to retire.

What is the single most important thing to fix before selling a veterinary practice?

Owner clinical dependence. If you personally produce 70 percent or more of the practice’s revenue, buyers see a job that disappears the day you leave, not a practice they can step into, and they price that risk in.

Bringing your own production below half of the total, by hiring associates and shifting cases to them over 18 to 24 months, is the change that most reliably moves the multiple. Buyers want to see two to three quarters of sustained associate production before they credit it in the underwriting.

How do I increase my veterinary practice’s value before I sell?

Five levers do most of the work. Reduce owner clinical dependence below half of total production.

Build a capable practice manager and documented systems so the practice runs without you. Show three consecutive years of revenue growth.

Protect and improve EBITDA margin through cleaner inventory, pricing, and staffing discipline. And document a defensible normalized EBITDA with add-backs that survive scrutiny.

Each lever can move the multiple a point or two over 12 to 24 months. The sixth and largest lever, running a competitive process rather than accepting a direct offer, happens at sale, not during preparation.

Should I commission my own Quality of Earnings audit before selling?

No. A Quality of Earnings audit is something the buyer’s accountants run before closing.

The seller’s equivalent is a pre-sale financial review run by your own advisor, built around the exact scrutiny the buyer’s team will apply but done on your side of the table before any buyer sees your numbers. That gives months to clean up questionable add-backs, revenue recognition, inventory valuation, and doctor productivity tracking, so the issues that would have cut your price are fixed before they ever surface.

It is advisor work, not an owner DIY project.

How much does owner dependence reduce a veterinary practice’s sale price?

Roughly 1 to 2 additional multiples of EBITDA. A practice with diversified doctor production that would clear at 9 times earnings often clears at 7 or 8 when the owner produces most of the clinical work.

On a practice doing $1 million in normalized EBITDA, that gap is $1 million to $2 million of headline sale value. The discount reverses slowly.

It takes 12 to 24 months of associate hiring and case-shifting before buyers will factor the improved production profile into their offer.

Do I need a practice manager to sell my veterinary practice for a higher multiple?

It is one of the most underweighted levers. A practice that depends on the owner’s daily attention to run is harder for a buyer to integrate, and the discount versus a practice with a real practice manager, defined roles, and documented systems runs roughly 1 to 2 additional multiples of EBITDA.

Building that management layer costs about 1 to 3 percent of revenue a year, which on a $4 million practice is roughly $40,000 to $120,000 annually, and the multiple uplift usually pays that back many times over inside the typical 18 to 24 month preparation window.

What financial records do buyers want when I sell my veterinary practice?

Three years of clean profit and loss statements, payroll summaries, production reports by doctor, tax returns, and a documented schedule of add-backs that ties to source records. Buyers also look at inventory valuation, revenue recognition, and doctor productivity that ties to actual schedules.

The goal of preparation is to have all of it organized, reconciled, and defensible before a buyer’s accountants ever ask, because the items that look sloppy or aggressive are the items that get used to walk the price down.

Is 2026 a good year to prepare a veterinary practice for sale?

Demand is healthy and supply is tight, which supports valuations. Capstone Partners‘ April 2026 Pet Sector M&A Update tracked 18 pet sector deals in the first months of 2026, more than double the same window of 2025, with Vet and Health accounting for half.

Annual transaction volume has settled near 350 practices a year, well below the 2021 peak, so well-prepared practices stand out in a thinner field of supply. Starting preparation now positions a practice to go to market in 12 to 24 months with the levers that move the multiple already in place.

---

Sources

Industry M&A research and valuation data

1. Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com
2. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion — VSOs Under Increasing Pressure.” 2025. octus.com
3. Mordor Intelligence. “Veterinary Medicine Market.” mordorintelligence.com

Veterinary practice operations, benchmarks, and profession data

4. AVMA. “2025 Report on the Economic State of the Veterinary Profession.” avma.org
5. AVMA. “Benchmarking data plus elevating efficiency equals practice productivity.” avma.org
6. AVMA. “Evolving pet owner economics: What data reveal for veterinary teams.” avma.org
7. AVMA. “Reports and statistics.” avma.org
8. AAHA. “Practice Ownership Exit (and Entry) Strategies.” Trends Magazine, July 2024. aaha.org
9. iVET360. “Understanding Your Animal Hospital’s EBITDA.” ivet360.com
10. Today’s Veterinary Business. “You, Your Legacy and Your Practice’s Future.” 2025. todaysveterinarybusiness.com

Legal and regulatory analysis

11. Dechert LLP. “Healthcare Investments Flash Alert — Latest Developments.” 2025. dechert.com
12. Holland & Knight. “Q1 Recap on Proposed Legislation Affecting Healthcare Consolidation.” 2026. hklaw.com